Fulcrum Therapeutics Inc (NAS:FULC)
$ 3.32 0.06 (1.84%) Market Cap: 207.17 Mil Enterprise Value: -60.70 Mil PE Ratio: 0 PB Ratio: 0.75 GF Score: 51/100

Q2 2023 Fulcrum Therapeutics Inc Earnings Call Transcript

Aug 03, 2023 / 12:00PM GMT
Release Date Price: $3.85 (+0.79%)
Operator

Good morning, and welcome to Fulcrum Therapeutics Second Quarter 2023 Financial Results and Business Update Conference Call. (Operator Instructions). This call is being webcast live on the Investors section of Fulcrum's website at www.fulcrumtx.com and is being recorded.

Please be reminded that remarks made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about the company's future expectations and plans, including the clinical hold on FTX-6058, clinical development time lines and financial projections. While these forward-looking statements represent Fulcrum's view as of today, this should not be relied upon as representing the company's views in the future. Fulcrum may update these statements in the future, but is not taking on an obligation to do so.

Please refer to Fulcrum's most recent filings with the Securities and Exchange Commission for a discussion of certain risks and uncertainties associated with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot